{
    "Trade/Device Name(s)": [
        "Cystatin C POC Test",
        "Cystatin POC Test Control Kit",
        "SMART Cystatin C Assay",
        "Diazyme Cystatin C POC Test Kit",
        "Diazyme Cystatin C POC Test Control Kit"
    ],
    "Submitter Information": "Diazyme Laboratories",
    "510(k) Number": "K111664",
    "Predicate Device Reference 510(k) Number(s)": [
        "K093680",
        "K092911"
    ],
    "Regulatory Class": "Class II (Assay), Class I (Control)",
    "Product Code(s)": [
        "NDY",
        "JJX"
    ],
    "Summary Letter Date": "March 15, 2012",
    "Summary Letter Received Date": "March 19, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1225",
        "21CFR862.1660"
    ],
    "Regulation Name(s)": [
        "Creatinine Test System",
        "Quality Control Material"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Cystatin C"
    ],
    "Specimen Type(s)": [
        "Venous whole blood"
    ],
    "Specimen Container(s)": [
        "DRS cuvette",
        "DRS cap"
    ],
    "Instrument(s)/Platform(s)": [
        "SMART analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Latex enhanced immunoturbidimetric assay"
    ],
    "Methodologies": [
        "Immunoturbidimetry"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Quality control material",
        "Calibration card"
    ],
    "Document Summary": "FDA 510(k) summary for Diazyme Cystatin C POC Test Kit for quantitative determination of Cystatin C in venous whole blood using SMART analyzer and latex enhanced immunoturbidimetric method.",
    "Indications for Use Summary": "For quantitative determination of Cystatin C in venous whole blood as an aid in diagnosis and treatment of renal disease, using SMART analyzer and latex enhanced immunoturbidimetric method; control kit for quality control use.",
    "fda_folder": "Clinical Chemistry"
}